· Strong sales growth of 6.0% in the second half, recovering from 5.6% shortfall in first half
· Full year revenue increased by 0.6% to £21.2m (2023:£21.1m)
· Underlying operating profit of £1.6m, excluding non-recurring costs
· Operating profit before valuation gain decreased by to £0.7m (2023: £1.8m), impacted by non-recurring costs of £0.9m
· EBITDA decreased to £1.1m (2023:£2.6m)
· Cash and cash equivalents at £2.1m (2023:£5.8m)
· Coronavirus Business Interruption Loan of £0.9m fully settled in December 2024
· Final dividend increased by 9.1% to 0.60p per ordinary share (2023:0.55p)